RNAi screens identify HES4 as a regulator of redox balance supporting pyrimidine synthesis and tumor growth

• Published in: Nature structural & molecular biology Vol. 31; no. 9; pp. 1413 - 1425
• Main Authors: He, Jing, Wang, Aoxue, Zhao, Qin, Zou, Yejun, Zhang, Zhuo, Sha, Nannan, Hou, Guofang, Zhou, Bei, Yang, Yi, Chen, Tao, Zhao, Yuzheng, Jiang, Yuhui
• Format: Journal Article
• Language: English
• Published: New York Nature Publishing Group US 01.09.2024; Nature Publishing Group
• Subjects: 13/1; 13/109; 13/51; 13/89; 14/19; 38/91; 45/77; 45/90; 631/1647/2163; 631/443/319; 631/80/83; 64/60; 692/699/67/1244; Adenocarcinoma; Biochemistry; Biological Microscopy; Biomedical and Life Sciences; Biosynthesis; Catabolism; Choline; Coenzyme Q; Deamination; Electron transport; Electron transport chain; Epidermal growth factor receptors; Genes; Life Sciences; Membrane Biology; Metabolism; Mitochondria; Modulation; NAD; Nicotinamide adenine dinucleotide; Nucleotides; Oxidation; Protein Structure; Pyrimidines; RNA-mediated interference; Serine; Tumors
• ISSN: 1545-9993; 1545-9985; 1545-9985
• DOI: 10.1038/s41594-024-01309-3

NADH/NAD + redox balance is pivotal for cellular metabolism. Systematic identification of NAD(H) redox regulators, although currently lacking, would help uncover unknown effectors critically implicated in the coordination of growth metabolism. In this study, we performed a genome-scale RNA interference (RNAi) screen to globally survey the genes involved in redox modulation and identified the HES family bHLH transcription factor HES4 as a negative regulator of NADH/NAD + ratio. Functionally, HES4 is shown to be crucial for maintaining mitochondrial electron transport chain (ETC) activity and pyrimidine synthesis. More specifically, HES4 directly represses transcription of SLC44A2 and SDS , thereby inhibiting mitochondrial choline oxidation and cytosolic serine deamination, respectively, which, in turn, ensures coenzyme Q reduction capacity for DHODH-mediated UMP synthesis and serine-derived dTMP production. Accordingly, inhibition of choline oxidation preserves mitochondrial serine catabolism and ETC-coupled redox balance. Furthermore, HES4 protein stability is enhanced under EGFR activation, and increased HES4 levels facilitate EGFR-driven tumor growth and predict poor prognosis of lung adenocarcinoma. These findings illustrate an unidentified mechanism, underlying pyrimidine biosynthesis in the intersection between serine and choline catabolism, and underscore the physiological importance of HES4 in tumor metabolism. The authors identify genes potentially involved in NAD(H) redox modulation and provide insight on major hit HES4, which uses its transcriptional repressive function to drive pyrimidine nucleotide biosynthesis and tumor growth.